Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lyceroplex-Z
- Development stage
- Unknown
- Lead developer
- Stadchem
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lyceroplex-Z is an oral nutritional supplement syrup developed and marketed by Stadchem. It is formulated as a combination of the essential amino acid L-lysine, vitamin B complex, zinc sulfate, and magnesium chloride. Lyceroplex-Z is primarily indicated for addressing nutritional deficiencies, managing general weakness or fatigue, and stimulating appetite in both children and adults. The combination of amino acids, vitamins, and minerals supports metabolic functions, energy production, and immune system health.
- Brand names
- Lyceroplex ZLyceroplex-Z
- Other names
- Lyceroplex Z SyrupLyceroplex-Z Syrup
Beyond the preview
Go deeper on Lyceroplex-Z.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lyceroplex-Z.